Palbociclib and Pembrolizumab In Central Nervous System Metastases

Clinical trial NCT02896335 · RECRUITING

Trial details

NCT number: NCT02896335
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm to Brain Recurrent Brain Metastases Progressive Brain Metastases

Start date: 2017-02-02
Primary completion: 2028-09-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.